(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are SEQUANA MEDICAL, KOMPLETT, and CNOVA.

Financial Asset	Price	Change	Updated (EST)
SEQUANA MEDICAL (SEQUA.BR)	4.35	25.72%	2023-12-12 12:21:22
KOMPLETT (KOMPL.OL)	9.75	11.43%	2023-12-12 12:40:52
CNOVA (CNV.PA)	2.20	10%	2023-12-12 13:01:16
THUNDERBIRD (TBIRD.AS)	0.08	9.59%	2023-12-12 12:04:00
INTEROIL EXPL PROD (IOX.OL)	0.64	9%	2023-12-12 12:40:35
EQVA (EQVA.OL)	3.59	8.79%	2023-12-12 12:25:58
ENSURGE MICROPOWER (ENSU.OL)	0.14	7.75%	2023-12-12 12:25:53
SOLVAY (SOLB.BR)	22.03	6.84%	2023-12-12 12:21:33
GENFIT (GNFT.PA)	3.49	6.25%	2023-12-12 13:04:07
ORPEA (ORP.PA)	0.02	5.59%	2023-12-12 13:21:04

The three biggest losers today are NORTHERN OCEAN LTD, BIOSENIC, and PCI BIOTECH HOLD.

Financial Asset	Price	Change	Updated (EST)
NORTHERN OCEAN LTD (NOL.OL)	10.04	-10.52%	2023-12-12 12:41:35
BIOSENIC (BIOS.BR)	0.05	-9.25%	2023-12-12 12:05:10
PCI BIOTECH HOLD (PCIB.OL)	2.02	-7.99%	2023-12-12 12:42:06
HYDROGENPRO (HYPRO.OL)	16.38	-6.83%	2023-12-12 12:40:28
METABOLIC EXPLORER (METEX.PA)	0.34	-6.29%	2023-12-12 13:20:23
XILAM ANIMATION (XIL.PA)	3.65	-6.17%	2023-12-12 13:25:00
AUREA (AURE.PA)	4.70	-6%	2023-12-12 12:46:02
BORGESTAD (BOR.OL)	0.26	-5.71%	2023-12-12 12:25:08
BIOTALYS (BTLS.BR)	3.20	-5.6%	2023-12-12 12:05:12
NORTHERN DRILLING (NODL.OL)	2.89	-5.25%	2023-12-12 12:41:33

Winners today

1. SEQUANA MEDICAL (SEQUA.BR)

25.72% Price Change

Sequana Medical NV develops and commercializes treatment of fluid overload in liver disease, cancer, and heart failure. The company's products include alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; Direct Sodium Removal (DSR) for the treatment of persistent congestion due to heart failure; and alfapump DSR, a fully implanted system for direct sodium removal therapy in patients with fluid overload due to heart failure. It operates in Belgium, Germany, France, Switzerland, and internationally. The company was founded in 2006 and is headquartered in Ghent, Belgium.

BEL 20 ended the session with SEQUANA MEDICAL rising 25.72% to €4.35 on Tuesday, after two successive sessions in a row of gains. BEL 20 rose 0.46% to €3,721.35, after two sequential sessions in a row of gains, on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, SEQUANA MEDICAL has a trailing twelve months EPS of €-1.32.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -690.43%.

Moving Average

SEQUANA MEDICAL’s worth is way above its 50-day moving average of €2.63 and way above its 200-day moving average of €3.48.

Volatility

SEQUANA MEDICAL’s last week, last month’s, and last quarter’s current intraday variation average was 5.54%, 1.54%, and 3.80%.

SEQUANA MEDICAL’s highest amplitude of average volatility was 6.53% (last week), 3.83% (last month), and 3.80% (last quarter).

More news about SEQUANA MEDICAL.

2. KOMPLETT (KOMPL.OL)

11.43% Price Change

Komplett ASA operates as an online retailer of electronics and IT products in Norway, Sweden, and Denmark. The company operates through three segments: Business to Consumer (B2C), Business to Business (B2B), and Distribution. It offers consumer electronics and business solutions, including computer components, gaming, PCs, household electronics, and other computer-related products, as well as brown and white goods, and cloud-based IT solutions and services. It operates webshops under the Komplett brand; and retail stores under the Webhallen brand. The company's B2B operations include sales to companies and public entities/institutions under the Komplett Bedrift and Komplett Företag. It also distributes products to resellers and other entities under the Itegra brand. The company was formerly known as Norkom ASA and changed its name to Komplett ASA in December 2002. Komplett ASA was founded in 1991 and is headquartered in Sandefjord, Norway.

Oslo Børs Benchmark Index_GI ended the session with KOMPLETT rising 11.43% to €9.75 on Tuesday, after two sequential sessions in a row of gains. Oslo Børs Benchmark Index_GI dropped 0.6% to €1,291.39, after two successive sessions in a row of gains, on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, KOMPLETT has a trailing twelve months EPS of kr-1.51.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.19%.

Sales Growth

KOMPLETT’s sales growth for the current quarter is 3.7%.

More news about KOMPLETT.

3. CNOVA (CNV.PA)

10% Price Change

Cnova N.V. operates as an e-commerce company in France and Western Europe. The company offers home appliances, consumer electronics, computers, home furnishings, and leisure and personal goods through its cdiscount.com website. It also operates Cdiscount Voyages, a travel platform; Cdiscount Mobile for cell phone plans; Cdiscount Advertising, a digital marketing solution; Octopia for turnkey marketplace solutions to retailers and e-merchants; and C-Logistics for transportation and logistics services. The company was founded in 1998 and is headquartered in Amsterdam, the Netherlands. Cnova N.V. is a subsidiary of Casino, Guichard-Perrachon S.A.

CAC 40 ended the session with CNOVA jumping 10% to €2.20 on Tuesday while CAC 40 dropped 0.11% to €7,543.55.

Earnings Per Share

As for profitability, CNOVA has a trailing twelve months EPS of €-0.35.

More news about CNOVA.

4. THUNDERBIRD (TBIRD.AS)

9.59% Price Change

Thunderbird Resorts, Inc., through its subsidiaries, engages in the gaming, hospitality, and real estate businesses in Nicaragua and Peru. It provides table and slot games, and sportsbooks. The company operates 3 slot parlors, 3 casinos, and 630 gaming positions. It develops, owns, and operates real estate properties; and rents office spaces. The company was formerly known as International Thunderbird Gaming Corporation and changed its name to Thunderbird Resorts, Inc. in July 2005. Thunderbird Resorts, Inc. was incorporated in 1987 and is headquartered in Panama, the Republic of Panama.

AEX-Index ended the session with THUNDERBIRD jumping 9.59% to €0.08 on Tuesday, after two sequential sessions in a row of gains. AEX-Index slid 0.04% to €786.13, after five successive sessions in a row of gains, on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, THUNDERBIRD has a trailing twelve months EPS of €0.02.

PE Ratio

THUNDERBIRD has a trailing twelve months price to earnings ratio of 4. Meaning, the purchaser of the share is investing €4 for every euro of annual earnings.

Volatility

THUNDERBIRD’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.72%, a negative 0.18%, and a positive 6.98%.

THUNDERBIRD’s highest amplitude of average volatility was 6.82% (last week), 9.50% (last month), and 6.98% (last quarter).

More news about THUNDERBIRD.

5. INTEROIL EXPL PROD (IOX.OL)

9% Price Change

Interoil Exploration and Production ASA, together with its subsidiaries, operates as an upstream oil exploration and production company. It engages in the acquisition, exploration, development, and operation of oil and natural gas properties. The company's portfolio includes two producing concessions and two exploration concessions in Colombia; and one exploration and seven production concessions in Argentina. Interoil Exploration and Production ASA was incorporated in 2005 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with INTEROIL EXPL PROD rising 9% to €0.64 on Tuesday, after two sequential sessions in a row of gains. Oslo Børs Benchmark Index_GI dropped 0.6% to €1,291.39, after two sequential sessions in a row of gains, on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, INTEROIL EXPL PROD has a trailing twelve months EPS of kr-0.41.

More news about INTEROIL EXPL PROD.

6. EQVA (EQVA.OL)

8.79% Price Change

Eqva ASA, a knowledge-based maritime company, primarily engages in the shipbuilding business worldwide. It operates in two segments, Shipbuilding Technology and Other. The company provides newbuilding, rebuilding, and service assignments on vessels for offshore oil production, renewable energy production, fishing, and fish farming for ship owners. It delivers technology for customers within the seafood, energy, and transport sectors. The company was formerly known as Havyard Group ASA and changed its name to Eqva ASA in November 2022. Eqva ASA was founded in 1999 and is headquartered in Fosnavåg, Norway.

Oslo Børs Benchmark Index_GI ended the session with EQVA jumping 8.79% to €3.59 on Tuesday while Oslo Børs Benchmark Index_GI fell 0.6% to €1,291.39.

Earnings Per Share

As for profitability, EQVA has a trailing twelve months EPS of kr-0.32.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -5.45%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 209.8%, now sitting on 594.65M for the twelve trailing months.

Volatility

EQVA’s last week, last month’s, and last quarter’s current intraday variation average was 0.24%, 1.36%, and 3.25%.

EQVA’s highest amplitude of average volatility was 2.64% (last week), 3.86% (last month), and 3.25% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EQVA’s stock is considered to be overbought (>=80).

Yearly Top and Bottom Value

EQVA’s stock is valued at kr3.59 at 21:40 EST, way below its 52-week high of kr4.00 and way above its 52-week low of kr2.56.

More news about EQVA.

7. ENSURGE MICROPOWER (ENSU.OL)

7.75% Price Change

Ensurge Micropower ASA manufactures and sells ultrathin energy storage solutions for wearable devices, connected sensors, and other applications. Its solid-state lithium battery technology enables it to produce rechargeable batteries. The company was formerly known as Thin Film Electronics ASA and changed its name to Ensurge Micropower ASA in June 2021. Ensurge Micropower ASA was incorporated in 2005 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with ENSURGE MICROPOWER jumping 7.75% to €0.14 on Tuesday, after two consecutive sessions in a row of gains. Oslo Børs Benchmark Index_GI fell 0.6% to €1,291.39, after two consecutive sessions in a row of gains, on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, ENSURGE MICROPOWER has a trailing twelve months EPS of kr-0.52.

Yearly Top and Bottom Value

ENSURGE MICROPOWER’s stock is valued at kr0.14 at 21:40 EST, way below its 52-week high of kr4.19 and way higher than its 52-week low of kr0.10.

Volatility

ENSURGE MICROPOWER’s last week, last month’s, and last quarter’s current intraday variation average was 0.32%, 1.52%, and 3.40%.

ENSURGE MICROPOWER’s highest amplitude of average volatility was 5.13% (last week), 3.47% (last month), and 3.40% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ENSURGE MICROPOWER’s stock is considered to be oversold (<=20).

Earnings Before Interest, Taxes, Depreciation, and Amortization

ENSURGE MICROPOWER’s EBITDA is -150.46.

More news about ENSURGE MICROPOWER.

8. SOLVAY (SOLB.BR)

6.84% Price Change

Solvay SA provides advanced materials and specialty chemicals worldwide. It operates through four segments: Materials, Chemicals, Solutions, and Corporate & Business Services. The Materials segment offers specialty polymers, including aromatic polymers, high barrier polymers, and fluoropolymers for the electronics, automotive, aerospace, and healthcare industries; and composite materials for aerospace engineered materials market. The Chemicals segment produces and sells soda ash and sodium bicarbonate primarily to the flat and container glass industries, as well as for use in detergents, pharmaceutical, and feed and food industries; hydrogen peroxide for use primarily in the paper industry to bleach pulp, as well as chemicals, electronics, food, mining, and environment; and dispersible silica for tire manufacturers; and solvent solutions, phenols and derivatives, polyamide derivatives and smart, functional, and sustainable yarns and polymers. The Solutions segment offers specialty chemicals for agro, home and personal care, coatings, and industrial markets; technology solutions in specialty mining reagents, phosphine-based chemistry, and solutions for the stabilization of polymers; fluorine and rare-earth formulations for automotive, electronics, agrochemical, and construction applications; and vanillin for the food, flavors, and fragrances industries, as well as value-added intermediates used in monomers and polymers, pharmaceuticals, agrochemicals, and electronics. This segment also provides various products for upstream oilfield chemicals sector, as well as sodium hypophosphite for metal plating and other applications; and PROBAN, a technological process that offers durable flame retardant properties to cotton-based textiles. The Corporate & Business Services segment provides energy and other business services. The company was founded in 1863 and is headquartered in Brussels, Belgium.

BEL 20 ended the session with SOLVAY rising 6.84% to €22.03 on Tuesday while BEL 20 jumped 0.46% to €3,721.35.

Earnings Per Share

As for profitability, SOLVAY has a trailing twelve months EPS of €10.23.

PE Ratio

SOLVAY has a trailing twelve months price to earnings ratio of 2.15. Meaning, the purchaser of the share is investing €2.15 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.93%.

More news about SOLVAY.

9. GENFIT (GNFT.PA)

6.25% Price Change

Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company develops Elafibranor, which is in Phase III clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagnosis of nonalcoholic steatohepatitis (NASH) and fibrosis; VS-01 for the treatment of Urea Cycle Disorder (UCD) and Organic Acidemia Disorder (OAD); GNS561, which is in Phase 1b/2 trial to treat patients with cholangiocarcinoma (CCA); and VS-01-ACLF and Nitazoxanide (NTZ), which is in Phase 1 trial to treat acute-on-chronic liver failure, as well as VS-02-HE, which is in preclinical trial for the treatment of Reduction of Hyperammonemia and the Stabilization of Blood Ammonia. The company has a licensing agreement with Labcorp for the commercialization of NASHnext, a blood-based molecular diagnostic test; and Genoscience Pharma to develop and commercialize the investigational treatment GNS561 for CCA. The company was incorporated in 1999 and is headquartered in Loos, France.

CAC 40 ended the session with GENFIT rising 6.25% to €3.49 on Tuesday while CAC 40 dropped 0.11% to €7,543.55.

Earnings Per Share

As for profitability, GENFIT has a trailing twelve months EPS of €-0.71.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -37.21%.

Yearly Top and Bottom Value

GENFIT’s stock is valued at €3.49 at 21:40 EST, way below its 52-week high of €4.92 and way higher than its 52-week low of €2.84.

Volatility

GENFIT’s last week, last month’s, and last quarter’s current intraday variation average was 2.59%, 0.35%, and 2.17%.

GENFIT’s highest amplitude of average volatility was 2.59% (last week), 1.77% (last month), and 2.17% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth grew by 24.5%, now sitting on 29.22M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, GENFIT’s stock is considered to be oversold (<=20).

More news about GENFIT.

10. ORPEA (ORP.PA)

5.59% Price Change

ORPEA SA operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals. Its nursing home facilities provide personalized support services; and logistical and residential services, including accommodation, meals, and laundry and room cleaning, as well as various daily event, entertainment, and therapeutic workshop services. The company's post-acute and rehabilitation hospitals offer services for geriatrics, musculoskeletal, nervous system, cardiovascular, hematology, and oncology conditions, as well as patients in a persistent vegetative state or in a minimally conscious state. Its psychiatric hospitals provide services for the patients with mood disorders, anxiety disorders, obsessive-compulsive disorders, addictions, eating disorders, sleep disorders, personality disorders, ageing-related psychiatric disorders, psychosis, over exhaustion or burn-out, chronic fatigue syndrome, fibromyalgia, psychosomatic conditions, and post-traumatic stress disorder conditions, as well as geriatric, child, young adult, parent-child, and public/private patients psychiatry services. In addition, the company offers home care services, including housekeeping services, such as cleaning, meals, ironing, gardening, and household errands; daily life assistance services comprising day or night supervision, assistance with hygiene tasks, and meal-time assistance; and movement assistance services. The company operates in France, Belgium, Spain, Italy, Ireland, Switzerland, Austria, Germany, the Czech Republic, Poland, the Netherlands, Luxembourg, Portugal, Brazil, Russia, Slovenia, Uruguay, Colombia, Mexico, Chile, Latvia, Croatia, and China. ORPEA SA was founded in 1989 and is headquartered in Puteaux, France.

CAC 40 ended the session with ORPEA jumping 5.59% to €0.02 on Tuesday while CAC 40 slid 0.11% to €7,543.55.

Earnings Per Share

As for profitability, ORPEA has a trailing twelve months EPS of €-4.11.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -445.48%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ORPEA’s stock is considered to be overbought (>=80).

Volume

Today’s last reported volume for ORPEA is 273141000 which is 368.75% above its average volume of 58269800.

Yearly Top and Bottom Value

ORPEA’s stock is valued at €0.02 at 21:40 EST, way below its 52-week high of €8.93 and way higher than its 52-week low of €0.01.

Revenue Growth

Year-on-year quarterly revenue growth grew by 10.7%, now sitting on 4.93B for the twelve trailing months.

More news about ORPEA.

Losers Today

1. NORTHERN OCEAN LTD (NOL.OL)

-10.52% Price Change

Northern Ocean Ltd., a drilling contractor, provides offshore contract drilling services for the oil and gas industry worldwide. The company was incorporated in 2017 and is based in Hamilton, Bermuda.

Oslo Børs Benchmark Index_GI ended the session with NORTHERN OCEAN LTD sliding 10.52% to €10.04 on Tuesday while Oslo Børs Benchmark Index_GI dropped 0.6% to €1,291.39.

Earnings Per Share

As for profitability, NORTHERN OCEAN LTD has a trailing twelve months EPS of kr-4.58.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -15.86%.

Yearly Top and Bottom Value

NORTHERN OCEAN LTD’s stock is valued at kr10.04 at 21:40 EST, way under its 52-week high of kr15.88 and way above its 52-week low of kr8.94.

Volatility

NORTHERN OCEAN LTD’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.34%, a negative 0.93%, and a positive 1.98%.

NORTHERN OCEAN LTD’s highest amplitude of average volatility was 4.15% (last week), 3.05% (last month), and 1.98% (last quarter).

Sales Growth

NORTHERN OCEAN LTD’s sales growth for the next quarter is 149.4%.

More news about NORTHERN OCEAN LTD.

2. BIOSENIC (BIOS.BR)

-9.25% Price Change

BioSenic S.A., a biotech company, focuses on developing clinical assets. Its technologies include cutting-edge allogeneic cell and gene therapy platform with differentiated bone marrow sourced mesenchymal stromal cells, which can be stored at the point of use in the hospital; and Arsenic TriOxide platform for use in immuno-oncology to treat graft-versus-host disease, systemic lupus erythematosus, and systemic sclerosis. The company's investigational medicinal product is ALLOB, which is in a Phase IIb clinical trial in patients with difficult tibial fractures' and ArsciCor, which is in Phase III in GvHD is being prepared with an oral treatment. BioSenic S.A. is based in Mont-Saint-Guibert, Belgium.

BEL 20 ended the session with BIOSENIC sliding 9.25% to €0.05 on Tuesday while BEL 20 rose 0.46% to €3,721.35.

Earnings Per Share

As for profitability, BIOSENIC has a trailing twelve months EPS of €7.53.

PE Ratio

BIOSENIC has a trailing twelve months price to earnings ratio of 0.01. Meaning, the purchaser of the share is investing €0.01 for every euro of annual earnings.

Volatility

BIOSENIC’s last week, last month’s, and last quarter’s current intraday variation average was 11.14%, 1.17%, and 8.62%.

BIOSENIC’s highest amplitude of average volatility was 18.24% (last week), 7.05% (last month), and 8.62% (last quarter).

More news about BIOSENIC.

3. PCI BIOTECH HOLD (PCIB.OL)

-7.99% Price Change

PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The company develops anticancer paradigms, including fimaCHEM, a chemotherapeutics for treatment of cancer; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is in pre-clinical study; and fimaNAc, a nucleic acid therapeutics delivery technology, which is in pre-clinical study. It also offers Amphinex, a photosensitiser fimaporfin. The company has collaborative research programs with Olix Pharmaceuticals, Aposense, IMV Immunovaccine, MDimune, eTheRNA, and Immunicum. PCI Biotech Holding ASA was incorporated in 2007 and is based in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with PCI BIOTECH HOLD falling 7.99% to €2.02 on Tuesday while Oslo Børs Benchmark Index_GI dropped 0.6% to €1,291.39.

Earnings Per Share

As for profitability, PCI BIOTECH HOLD has a trailing twelve months EPS of kr-0.79.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -47.54%.

Yearly Top and Bottom Value

PCI BIOTECH HOLD’s stock is valued at kr2.02 at 21:40 EST, way below its 52-week high of kr5.93 and way higher than its 52-week low of kr1.20.

More news about PCI BIOTECH HOLD.

4. HYDROGENPRO (HYPRO.OL)

-6.83% Price Change

HydrogenPro ASA designs and supplies customized hydrogen plants. It provides high-pressure alkaline electrolysers. The company was incorporated in 2013 and is headquartered in Porsgrunn, Norway.

Oslo Børs Benchmark Index_GI ended the session with HYDROGENPRO falling 6.83% to €16.38 on Tuesday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI dropped 0.6% to €1,291.39, after two successive sessions in a row of gains, on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, HYDROGENPRO has a trailing twelve months EPS of kr-0.95.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -12.28%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, HYDROGENPRO’s stock is considered to be oversold (<=20).

Yearly Top and Bottom Value

HYDROGENPRO’s stock is valued at kr16.38 at 21:40 EST, way under its 52-week high of kr36.90 and way above its 52-week low of kr12.90.

Earnings Before Interest, Taxes, Depreciation, and Amortization

HYDROGENPRO’s EBITDA is 2.14.

Volume

Today’s last reported volume for HYDROGENPRO is 138146 which is 18.78% above its average volume of 116304.

More news about HYDROGENPRO.

5. METABOLIC EXPLORER (METEX.PA)

-6.29% Price Change

METabolic EXplorer S.A., a biological chemistry company, engages in the development and industrialization of industrial fermentation processes as alternatives to petrochemical processes worldwide. The company also offers propanediol, butyric acid, butyric acid, glycolic acid, amino acid, and L-Valine. Its products are used in the formulation of cosmetics, textiles, polymer, animal nutrition, and health products or as intermediates for the synthesis of biomaterials. The company was incorporated in 1999 and is based in Saint-Beauzire, France.

CAC 40 ended the session with METABOLIC EXPLORER falling 6.29% to €0.34 on Tuesday while CAC 40 dropped 0.11% to €7,543.55.

Earnings Per Share

As for profitability, METABOLIC EXPLORER has a trailing twelve months EPS of €-0.98.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -42.82%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 46.2%, now sitting on 168.16M for the twelve trailing months.

Moving Average

METABOLIC EXPLORER’s worth is way below its 50-day moving average of €0.41 and way below its 200-day moving average of €0.85.

Volatility

METABOLIC EXPLORER’s last week, last month’s, and last quarter’s current intraday variation average was a negative 3.75%, a negative 1.91%, and a positive 6.19%.

METABOLIC EXPLORER’s highest amplitude of average volatility was 4.61% (last week), 3.09% (last month), and 6.19% (last quarter).

More news about METABOLIC EXPLORER.

6. XILAM ANIMATION (XIL.PA)

-6.17% Price Change

Xilam Animation operates as an audiovisual production company in France and internationally. The company creates, produces, and distributes original programs for children and adults. It also broadcasts content on television; subscription video on demand streaming platforms, including Netflix, Disney +, Amazon, and NBC Universal; and advertising video on demand streaming platforms, such as YouTube and Facebook. In addition, the company produces animated, series, mini-series, and feature films. It owns the Oggy, Cockroaches, Zig & Sharko, Chicky, Oggy Oggy in preschool, Oggy Next Gen, Les Tales of Lupin, Moka, Mr Magoo, Trico, and I Lost My Body brands. The company was incorporated in 1999 and is headquartered in Paris, France.

CAC 40 ended the session with XILAM ANIMATION dropping 6.17% to €3.65 on Tuesday while CAC 40 slid 0.11% to €7,543.55.

Earnings Per Share

As for profitability, XILAM ANIMATION has a trailing twelve months EPS of €0.08.

PE Ratio

XILAM ANIMATION has a trailing twelve months price to earnings ratio of 45.63. Meaning, the purchaser of the share is investing €45.63 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.96%.

More news about XILAM ANIMATION.

7. AUREA (AURE.PA)

-6% Price Change

Aurea SA engages in the recycling of black motor oil in France. The company is also involved in the manufacturing of remold tires from used tires and recycling rigid PVC. It recycles plastics and packaging products; refines and recycles aluminum; recycles copper and produces copper alloys; and treats and recycles zinc, lead, and cadmium. In addition, the comany engages in the treatment and decontamination of mercury waste. The company was formerly known as AUER and changed its name to Aurea SA in 1988. Aurea SA is based in Paris, France.

CAC 40 ended the session with AUREA sliding 6% to €4.70 on Tuesday, after two successive sessions in a row of losses. CAC 40 fell 0.11% to €7,543.55, after two sequential sessions in a row of gains, on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, AUREA has a trailing twelve months EPS of €0.74.

PE Ratio

AUREA has a trailing twelve months price to earnings ratio of 6.35. Meaning, the purchaser of the share is investing €6.35 for every euro of annual earnings.

More news about AUREA.

8. BORGESTAD (BOR.OL)

-5.71% Price Change

Borgestad ASA develops, manufactures, distributes, and installs refractory products in Norway. The company also develops and manages real estate properties. Its properties include Agora Bytom, a shopping center with a gross area of 52,000 square meters and a rental area of approximately 30,000 square meters, as well as a parking garage with 820 parking lots in Poland. Borgestad ASA was founded in 1904 and is headquartered in Skien, Norway.

Oslo Børs Benchmark Index_GI ended the session with BORGESTAD falling 5.71% to €0.26 on Tuesday while Oslo Børs Benchmark Index_GI slid 0.6% to €1,291.39.

Earnings Per Share

As for profitability, BORGESTAD has a trailing twelve months EPS of kr-0.3.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -15.11%.

Moving Average

BORGESTAD’s worth is way below its 50-day moving average of kr1.50 and way under its 200-day moving average of kr1.46.

Revenue Growth

Year-on-year quarterly revenue growth grew by 31.8%, now sitting on 1.02B for the twelve trailing months.

More news about BORGESTAD.

9. BIOTALYS (BTLS.BR)

-5.6% Price Change

Biotalys NV, an agricultural technology company, discovers and develops novel biological products for the protection of food and crops. It primarily develops biofungicides, bioinsecticides, and biobactericides. The company was formerly known as Agrosavfe NV. Biotalys NV was incorporated in 2013 and is headquartered in Gent, Belgium.

BEL 20 ended the session with BIOTALYS falling 5.6% to €3.20 on Tuesday, after four successive sessions in a row of gains. BEL 20 jumped 0.46% to €3,721.35, after two consecutive sessions in a row of gains, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, BIOTALYS has a trailing twelve months EPS of €-0.76.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, BIOTALYS’s stock is considered to be oversold (<=20).

More news about BIOTALYS.

10. NORTHERN DRILLING (NODL.OL)

-5.25% Price Change

Northern Drilling Ltd. operates as an offshore drilling contractor to the oil and gas industry. The company primarily engages in acquiring and operating offshore drilling assets, as well as involved in drilling in ultra-deep water environments. Northern Drilling Ltd. was incorporated in 2017 and is based in Hamilton, Bermuda.

Oslo Børs Benchmark Index_GI ended the session with NORTHERN DRILLING falling 5.25% to €2.89 on Tuesday while Oslo Børs Benchmark Index_GI dropped 0.6% to €1,291.39.

Earnings Per Share

As for profitability, NORTHERN DRILLING has a trailing twelve months EPS of kr-6.11.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.22%.

Moving Average

NORTHERN DRILLING’s value is way above its 50-day moving average of kr2.33 and way below its 200-day moving average of kr21.19.

More news about NORTHERN DRILLING.

Stay up to date with our winners and losers daily report